STAT+: Pharma wins a round in a battle with HHS over a drug discount program for hospitals
In a victory for the pharmaceutical industry, a federal judge temporarily blocked the federal government from imposing a hotly contested rule for handling disputes over a program that provides discounted drugs to hospitals and clinics serving mostly low-income populations.
The ruling granted a preliminary injunction sought by Eli Lilly (LLY), which filed a lawsuit arguing the Department of Health and Human Services improperly implemented a rule in attempting to settle a clash between several drug makers and hospitals.
Continue to STAT+ to read the full story…
